These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7654098)

  • 1. [Antibacterial activity and toxicity of a new nitrofuran].
    Terekhov VI; Pavlov PA
    Antibiot Khimioter; 1995 Apr; 40(4):34-6. PubMed ID: 7654098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of resistance to difuracil (PAP-49) in bacteria and its activity in combination with other antibacterial drugs].
    Pavlov PA
    Antibiot Khimioter; 1997; 42(8):34-7. PubMed ID: 9412411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis.
    Zorzi RR; Jorge SD; Palace-Berl F; Pasqualoto KF; Bortolozzo Lde S; de Castro Siqueira AM; Tavares LC
    Bioorg Med Chem; 2014 May; 22(10):2844-54. PubMed ID: 24751553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the sensitivity of enteropathogenic bacteria to nifurzide].
    Gavinet AM; Mégraud F
    Pathol Biol (Paris); 1987 May; 35(5):542-4. PubMed ID: 3302859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial susceptibility of anaerobes by agar dilution method.
    Chakraborti CK; Chatterjee BD
    J Indian Med Assoc; 1991 May; 89(5):132-4. PubMed ID: 1748779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined action of nitrofuran preparations and bile acids on staphylococci].
    Tkachuk NI
    Antibiotiki; 1984 Mar; 29(3):188-91. PubMed ID: 6732204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
    Zhang FF; Zhao CJ; Wang ZW; Liu WY; Yan W; Peng QS; Jiang S; Guo Y; Liu JB; Chen HB; Li HN; Wang Q; Wang H
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):474-9. PubMed ID: 24059993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effectiveness of furazolidone and difuracil (PAP-49) in experimental staphylococcal and Escherichia septicemia].
    Terekhov VI; Pavlov PA
    Antibiot Khimioter; 1995 Apr; 40(4):37-9. PubMed ID: 7654099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
    Giacometti A; Cirioni O; Riva A; Kamysz W; Silvestri C; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1494-6. PubMed ID: 17220421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Joint action of ethonium and antibiotics on gram-positive and gram-negative microorganisms].
    Gudz' OV; Pis'ko GT
    Antibiotiki; 1982; 27(9):672-4. PubMed ID: 6756299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of difuracil (PAP-49) on normal intestinal microflora of rabbits. In vitro and in vivo experiments].
    Terekhov VI
    Antibiot Khimioter; 1997; 42(8):31-3. PubMed ID: 9412410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimicrobial potential of nitrofuran-triazole congeners.
    Kamal A; Hussaini SM; Sucharitha ML; Poornachandra Y; Sultana F; Ganesh Kumar C
    Org Biomol Chem; 2015 Sep; 13(36):9388-97. PubMed ID: 26238045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Joint action of nitrofuran preparations and bile acids on bacteria of the genus Proteus].
    Sytnik IA; Puzakova EV
    Antibiotiki; 1975; 20(12):1104-7. PubMed ID: 1225184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.
    Dupuis M; Leclercq R
    Antimicrob Agents Chemother; 2006 Jan; 50(1):237-42. PubMed ID: 16377692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of bifidobacteria.
    Lim KS; Huh CS; Baek YJ
    J Dairy Sci; 1993 Aug; 76(8):2168-74. PubMed ID: 8408866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic sensitivity of opportunistic bacteria isolated from patients].
    Arons RM; Chursina TV; Shub GM; Kontareva KIu
    Antibiotiki; 1982; 27(7):517-21. PubMed ID: 7137975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological and pharmacological evaluation, in mice and rats, of a new nitrofuran: 2-amino-4-methyl-6-(2-ethinyl-5-nitrofuryl)-pyrimidine (nifurpyrimidine).
    Castelli M; Genedani S; Bertolini A
    Chemotherapy; 1979; 25(2):91-5. PubMed ID: 446189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
    Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.